131 related articles for article (PubMed ID: 36720841)
21. Spread through air spaces (STAS) is a predictor of poor outcome in atypical carcinoids of the lung.
Altinay S; Metovic J; Massa F; Gatti G; Cassoni P; Scagliotti GV; Volante M; Papotti M
Virchows Arch; 2019 Sep; 475(3):325-334. PubMed ID: 31201506
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor.
Vesterinen T; Mononen S; Salmenkivi K; Mustonen H; Räsänen J; Salo JA; Ilonen I; Knuuttila A; Haglund C; Arola J
Acta Oncol; 2018 Aug; 57(8):1109-1116. PubMed ID: 29463166
[TBL] [Abstract][Full Text] [Related]
23. Orthopedia homeobox protein (OTP) is a sensitive and specific marker for primary pulmonary carcinoid tumors in cytologic and surgical specimens.
Viswanathan K; Borczuk AC; Siddiqui MT
J Am Soc Cytopathol; 2019; 8(1):39-46. PubMed ID: 30929758
[TBL] [Abstract][Full Text] [Related]
24. Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms.
Rubino M; Scoazec JY; Pisa E; Faron M; Spaggiari L; Hadoux J; Spada F; Planchard D; Cella CA; Leboulleux S; De Marinis F; Ducreux M; Lamartina L; Baudin E; Fazio N
Lung Cancer; 2020 Oct; 148():149-158. PubMed ID: 32916569
[TBL] [Abstract][Full Text] [Related]
25. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors.
Dermawan JKT; Farver CF
Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
[TBL] [Abstract][Full Text] [Related]
26. Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung.
Garg R; Bal A; DAS A; Singh N; Singh H
Turk Patoloji Derg; 2019; 35(1):15-21. PubMed ID: 30070306
[TBL] [Abstract][Full Text] [Related]
27. Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity.
Laitinen KL; Soini Y; Mattila J; Pääkkö P
Cancer; 2000 Apr; 88(7):1590-8. PubMed ID: 10738217
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids.
Daddi N; Schiavon M; Filosso PL; Cardillo G; Ambrogi MC; De Palma A; Luzzi L; Bandiera A; Casali C; Ruffato A; De Angelis V; Andriolo LG; Guerrera F; Carleo F; Davini F; Urbani M; Mattioli S; Morandi U; Zannini P; Gotti G; Loizzi M; Puma F; Mussi A; Ricci A; Oliaro A; Rea F;
Eur J Cardiothorac Surg; 2014 Apr; 45(4):677-86. PubMed ID: 24099733
[TBL] [Abstract][Full Text] [Related]
29. Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.
Fabbri A; Cossa M; Sonzogni A; Papotti M; Righi L; Gatti G; Maisonneuve P; Valeri B; Pastorino U; Pelosi G
Virchows Arch; 2017 Feb; 470(2):153-164. PubMed ID: 28054150
[TBL] [Abstract][Full Text] [Related]
30. Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations.
Simbolo M; Barbi S; Fassan M; Mafficini A; Ali G; Vicentini C; Sperandio N; Corbo V; Rusev B; Mastracci L; Grillo F; Pilotto S; Pelosi G; Pelliccioni S; Lawlor RT; Tortora G; Fontanini G; Volante M; Scarpa A; Bria E
J Thorac Oncol; 2019 Sep; 14(9):1651-1661. PubMed ID: 31085341
[TBL] [Abstract][Full Text] [Related]
31. [Proliferative activity in pulmonary carcinoids].
Resl M; Bukac J; Simek J; Siller J; Rothröckel P
Cesk Patol; 2000 Jan; 36(1):32-4. PubMed ID: 10838756
[TBL] [Abstract][Full Text] [Related]
32. [Typical and atypical pulmonary carcinoids--pathologic and clinical analysis of 77 cases].
Słodkowska J; Langfort R; Rudziński P; Kupis W
Pneumonol Alergol Pol; 1998; 66(5-6):297-303. PubMed ID: 9857650
[TBL] [Abstract][Full Text] [Related]
33. Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors.
Walts AE; Ines D; Marchevsky AM
Mod Pathol; 2012 Sep; 25(9):1258-64. PubMed ID: 22575865
[TBL] [Abstract][Full Text] [Related]
34. Role of orthopedia homebox protein in subclassification of pulmonary carcinoid tumors: Retrospective analysis of 110 cases.
Çetin M; Fındık G; Demirağ F; Türk İ; Aydoğdu K
Indian J Pathol Microbiol; 2023; 66(4):786-789. PubMed ID: 38084533
[TBL] [Abstract][Full Text] [Related]
35. ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of China.
Hu C; Dong J; Liu L; Liu J; Sun X; Teng F; Wang X; Ying J; Li J; Xing P; Yang L
Thorac Cancer; 2022 Feb; 13(3):338-345. PubMed ID: 34931456
[TBL] [Abstract][Full Text] [Related]
36. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
Correia Sda S; Pinto C; Bernardo J
Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
[TBL] [Abstract][Full Text] [Related]
37. Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung.
Tsuta K; Raso MG; Kalhor N; Liu DD; Wistuba II; Moran CA
Lung Cancer; 2011 Jan; 71(1):34-41. PubMed ID: 20462655
[TBL] [Abstract][Full Text] [Related]
38. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.
Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP
Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848
[TBL] [Abstract][Full Text] [Related]
39. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism in ASCL1 target gene DDC is associated with clinical outcomes of small cell lung cancer patients.
Kim JH; Lee SY; Choi JE; Do SK; Lee JH; Hong MJ; Kang HG; Lee WK; Shin KM; Jeong JY; Choi SH; Lee YH; Seo H; Yoo SS; Lee J; Cha SI; Kim CH; Park JY
Thorac Cancer; 2020 Jan; 11(1):19-28. PubMed ID: 31691490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]